Tuesday, April 12, 2022

< + > Remdesivir Resistance Reported Upon Treatment Of An Immunocompromised Patient

One of the questions that arises with any single drug treatment of an RNA virus is the level of resistance. Remdesivir has been approved as a stand-alone therapy for the treatment and prevention of COVID-19.

at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

< + > Bonus Features – March 22, 2026 – 54% of providers have used non-clinical resources to learn about preventive care, 47% of orgs report low perceptions of safety culture, plus 20 more stories

Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...